首页> 外文会议>World Asthma and COPD Forum >Immunologic Signs of Fibrous Changes Debut in the Liver of Patients with Chronic Hepatitis B
【24h】

Immunologic Signs of Fibrous Changes Debut in the Liver of Patients with Chronic Hepatitis B

机译:纤维变化的免疫迹象在慢性乙型肝炎患者肝脏中亮相

获取原文

摘要

There are some problems of registration of liver fibrosis initial changes in patients with chronic hepatitis B. The authors stated that criteria indices of the immune state connected with the possibility to prognose debut of liver fibrous changes can be quantitative characteristics of content in blood of monocytes, T cell subsets, especially with cytotoxic activity (CD3+/CD8+), NKT (CD3+/CD56+) and their subpopulations (CD4+, CD8+, DN), some indices of functional state of natural killer cells. All these indices in defined range values comprise the unique criteria complex of fibrous changes start in the liver of chronic hepatitis B patients and spillover of criteria range values (while monitoring of the disease) means active progress of fibrosis process.
机译:肝纤维化患者的肝纤维化初始变化存在一些问题,提交人指出,与肝纤维变化的肝纤维变化的可能性相连的免疫状态标准索引可以是单核细胞血液中含量的定量特征, T细胞亚群,尤其是细胞毒性活性(CD3 + / CD8 +),NKT(CD3 + / CD56 +)及其亚群(CD4 +,CD8 +,DN),一些自然杀伤细胞功能状态的指标。定义范围值中的所有这些指数包括纤维变化的唯一标准复合体,从慢性乙型肝炎患者的肝脏开始,标准范围值的溢出(同时监测疾病)是指纤维化过程的积极进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号